EDIUNET Free equity investment tool of Japanese companies

Companies Cart
@
Credit Rating Analysis
Annual
First quarter
Second quarter
Third quarter
Sponsored Link
Related Company
@ SAYLOR ADVERTISING.
@ YASKAWA INFORMATION SYSTEMS
@ SAYLOR ADVERTISING.
@ CSS HOLDINGS
@ CRIE ANABUKI
@ LEGS
@ Oricon
@ JPN Holdings
@ Keyware Solutions
@ I'rom Holdings
@ Synergy Marketing
@ Aeria
@ KYOWA ENGINEERING CONSULTANTS
@ Japan Reliance Service Co.
@ インサイト
EDIUNET Related Ranking
EDIUNET
EDIUNET Credit Rating
EDIUNET Industry Avg
EDIUNET Prefectures
Yuho! Industry
EDIUNET Rating News
Prev « 2024-03 » Next
Mon Tue Wed Thu Fri Sat Sun
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
[Update list]
1/28 Retail Trade (CAWACHI:A etc...
1/27 Banks (The Awa Bank:BBB→A)
1/23 Chemicals (Milbon:AA→AAA)
1/21 Glass & Ceramics Products (..
1/21 Machinery (TSUDAKOMA:C)
1/21 Other Services (Netindex.:CC)
1/20 Other Products (Kurogane Kos..
1/20 Wholesale Trade (リーバイ・..
1/20 Other Services (川崎地質:BB→..
1/17 Chemicals (Kawaguchi Chemica..
 RSS
 Company RSS
 Daily RSS
Sponsored Link
Recently Download Chart
Hitachi Zosen etc.
graph
日本アビオニクス
graph
日本アビオニクス
graph
日本アビオニクス
graph
日本セラミック
graph

Credit Rating Analysis: SHIN NIPPON BIOMEDICAL LABORATORIES (Annual )

The details of credit rating (bankruptcy risk) can be checked. A credit rating in nine stages (AAA-C).

【Analysis Menu】 @Outline @Statement @Rating @Indicator @Download

Sponsored Link

Credit Rating (Bankruptcy Risk): SHIN NIPPON BIOMEDICAL LABORATORIES (Annual ) Consolidated | Non-Consolidated

Date Credit Rating Comment Sales Current Profit Net Income
2013-03-31  CCC  Credit is fragile, and depended on biz environs. ¥ 17 B
12.31%
¥ -490 M
82.76%
¥ -1 B
65.13%

Financial Timeline

Date  2012-12-31 
(Third quarter )
 2013-03-31 
(Annual )
 2013-06-30 
(First quarter )
 2013-09-30 
(Second quarter )
Credit Rating CCCCCCCC
Total Assets
¥ 36 B
¥ 35 B
¥ 33 B
¥ 38 B
Net Assets
¥ 2 B
¥ 2 B
¥ 2 B
¥ 6 B

Financial Statement Risk Analysis: SHIN NIPPON BIOMEDICAL LABORATORIES (Annual ) (Consolidated )

Special note
The change of Net income is going too far. The management situation is unstable.
[Date: 2013-03-31]  Danger : Warning : Caution : Good
Management Risk (*Cumulative loss)
Earned Surplus etc. (¥ -2 B) is minus, so Cumulative loss , there is a possibility that the management situation is severe.
Management Risk (*Net Income is minus or 0 )
Net Income (¥ -1 B) is minus or 0, so , there is a possibility that the management situation is severe.
Overinvestment Risk (*Investment Cash Flow confirmed content)
Net Income (¥ -1 B) is a minus, the cashflow of Operating Cash Flow (¥ 90 M) is smaller than Investment Cash Flow (¥ -750 M) , there is a possibility of the overinvestment.
[Date: 2012-03-31]  Danger : Warning : Caution : Good
Management Risk (*Cumulative loss)
Earned Surplus etc. (¥ -1 B) is minus, so Cumulative loss , there is a possibility that the management situation is severe.
Management Risk (*Net Income & Operating Cash Flow is minus or 0 )
Net Income(¥ -3 B) & Operating Cash Flow (¥ -1 B) is minus or 0, so , there is a possibility that the management situation is very severe.
Management Risk (*Sales is decrease )
Sales (¥ 15 B) is first term Sales (¥ 17 B) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Net Income is decrease )
Net Income (¥ -3 B) is first term Net Income (¥ -1 B) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (-21.63%) is first term Net Profit Margin (-8.30%) less , there is a possibility that the profitability has deteriorated.
Dividend Risk
Under the situation of Net Income (¥ -3 B) & Operating Cash Flow (¥ -1 B), Dividend (¥ -103 M) is paid.
Overinvestment Risk (*Intangible Assets confirmed content)
Operating Cash Flow (¥ -1 B) and Investment Cash Flow (¥ -1 B) is minus, so , there is a possibility of the overinvestment.
[Date: 2011-03-31]  Danger : Warning : Caution : Good
Management Risk (*Net Income is minus or 0 )
Net Income (¥ -1 B) is minus or 0, so , there is a possibility that the management situation is severe.
Management Risk (*Sales is decrease )
Sales (¥ 17 B) is first term Sales (¥ 19 B) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Net Income is decrease )
Net Income (¥ -1 B) is first term Net Income (¥ 534 M) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (-8.30%) is first term Net Profit Margin (2.81%) less , there is a possibility that the profitability has deteriorated.
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -849 M) & Financial Cash Flow (¥ -342 M) is a minus, Operating Cash Flow (¥ 306 M) is a plus,
Dividend Risk
Under the situation of Net Income (¥ -1 B) & Operating Cash Flow (¥ 306 M), Dividend (¥ -98 M) is paid.
Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ -672 M) is Sales first term ratio (¥ -1 B) more , there is a possibility that the non-performing asset was increased.
Overinvestment Risk (*Investment Cash Flow confirmed content)
Net Income (¥ -1 B) is a minus, the cashflow of Operating Cash Flow (¥ 306 M) is smaller than Investment Cash Flow (¥ -849 M) , there is a possibility of the overinvestment.
[Date: 2010-03-31]  Danger : Warning : Caution : Good
Management Risk (*Sales is decrease )
Sales (¥ 19 B) is first term Sales (¥ 19 B) less , there is a possibility that the management situation has stagnated and deteriorated
Dividend
Under the situation of Net Income (¥ 534 M) & Operating Cash Flow (¥ 1 B) , Dividend (¥ -100 M) is paid.
Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 841 M) is Sales first term ratio (¥ -489 M) more , there is a possibility that the non-performing asset was increased.
[Date: 2009-03-31]  Danger : Warning : Caution : Good
Management Risk (*Net Income is minus or 0 )
Net Income (¥ -205 M) is minus or 0, so , there is a possibility that the management situation is severe.
Dividend Risk
Under the situation of Net Income (¥ -205 M) & Operating Cash Flow (¥ 868 M), Dividend (¥ -206 M) is paid.
Overinvestment Risk (*Investment Cash Flow confirmed content)
Net Income (¥ -205 M) is a minus, the cashflow of Operating Cash Flow (¥ 868 M) is smaller than Investment Cash Flow (¥ -2 B) , there is a possibility of the overinvestment.

Related Information: SHIN NIPPON BIOMEDICAL LABORATORIES (Annual )

Statement Type
Annual : SHIN NIPPON BIOMEDICAL LABORATORIES
First quarter : SHIN NIPPON BIOMEDICAL LABORATORIES
Second quarter : SHIN NIPPON BIOMEDICAL LABORATORIES
Third quarter : SHIN NIPPON BIOMEDICAL LABORATORIES
Analysis Menu
@Outline : SHIN NIPPON BIOMEDICAL LABORATORIES
@Statement : SHIN NIPPON BIOMEDICAL LABORATORIES
@Rating : SHIN NIPPON BIOMEDICAL LABORATORIES
@Indicator : SHIN NIPPON BIOMEDICAL LABORATORIES
@Download : SHIN NIPPON BIOMEDICAL LABORATORIES
Industry Comparison Ranking
Other Services - EDIUNET Industry Rankings
Other Services - EDIUNET Credit Rating
Other Services - EDIUNET Industry Avg
Comparison with a neighboring company
Kagoshima - EDIUNET Prefectures
Kagoshima鹿児島市 - EDIUNET Prefectures

Related company's newest statement

Date Company Credit Rating Date
1/21 Netindex. CC 2013-11-30
1/20 川崎地質 BB→BBB 2013-11-30
1/20 KYOWA ENGINEERING CONSU.. B→BB 2013-11-30
1/20 KG Intelligence AAA→AA 2013-12-20
1/16 アクトコール -→B 2013-11-30
1/16 S-Pool C→CC 2013-11-30
1/16 T&C HOLDINGS C 2013-11-30
1/15 HITO -→AAA 2013-11-30 (Q1)
1/15 Pasona Group CC 2013-11-30 (Q2)
1/15 乃村工藝社 BB→BBB 2013-11-30 (Q3)

Ticker Market Industry Month report Rating
@ SHIN NIPPON BIOMEDICAL LABORATORIES 2395 TSE 1st Other Services 3 Annual CCC

Related Company

@ JAPAN THIRD PARTY (Sales ¥ 4 B)
@ JPN Holdings (Sales ¥ 7 B)
@ TOKAI LEASE (Sales ¥ 12 B)
@ Broadmedia (Sales ¥ 12 B)
@ Aeria (Sales ¥ 6 B)
@ SHIN NIPPON BIOMEDICAL LABORATORIES (Sales ¥ 17 B)
@ Oricon (Sales ¥ 5 B)
@ The First Energy Service (Sales ¥ 6 B)
@ SAYLOR ADVERTISING. (Sales ¥ 8 B)
@ インサイト (Sales ¥ 1 B)
@ Synergy Marketing (Sales ¥ 3 B)
@ Keyware Solutions (Sales ¥ 15 B)
@ I-FREEK HOLDINGS (Sales ¥ 2 B)
Sponsored Link


関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

  1. Guide
  2. Mobile
  3. Tablet
  4. Japanese
`EDIUNET` Copyright©2006-2024 `MAバンク` (0.084 sec.)